Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
M., Hauser, B
Peer review Peer review information Nature Reviews Urology thanks the anonymous reviewers for their contribution to the peer review of this work
Manufactured under cGMP-equivalent protocols and verified to 99% purity via HPLC
It was clinically approved by both the Food and Drug Administration (FDA) and the European Medicine Agency (EMA) in 2014 for the treatment of relapsing-remitting multiple sclerosis (MS), showing a significant efficacy over 2 years versus placebo and a favorable benefit-risk profile in two phase-III clinical trials, although with several adverse effects such as nausea, diarrhea, abdominal pain and leukopenia in some patients [282, 283]
US$ 28.86
US$ 23.66
US$ 24.42
